These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11134760)

  • 1. Intensive chemotherapy with peripheral progenitor stem cell support: experience of the Hematology Department of São João hospital, Oporto, Portugal.
    Príncipe F; Duarte R; Granato C; Parreira MJ; Ribeiro M
    Transplant Proc; 2000 Dec; 32(8):2678-9. PubMed ID: 11134760
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.
    Lazarus HM; Phillips GL; Herzig RH; Hurd DD; Wolff SN; Herzig GP
    J Clin Oncol; 2008 May; 26(14):2240-3. PubMed ID: 18467711
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study on the peripheral blood stem cells mobilization, collection and their effects on engraftment].
    Wang L; Yu T; Zhao X
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):659-62. PubMed ID: 8731824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
    Ke X; Yang Y; Zhao X; Wang L
    Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change of adhesion molecule expression on CD34(+) cells from bone marrow and peripheral blood during mobilization with combination of chemotherapy and G-CSF].
    Da WM; Zhang M; Zhang BL; Jin HJ; Yu L; Han XP; Jing Y; Zhao Y; Wu XX; Huang WR; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):240-2. PubMed ID: 12513794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the collection efficiency and characteristics of peripheral blood progenitor cells mobilized by G-CSF administration in the steady state versus postmyelosuppressive chemotherapy.
    Masauzi N; Kobayashi N; Suzuki G; Ohizumi H; Ogasawara M; Kiyama Y; Naohara T; Saitoh M; Higa T; Kasai M
    Transplant Proc; 1996 Jun; 28(3):1741-5. PubMed ID: 8658864
    [No Abstract]   [Full Text] [Related]  

  • 7. Biannual report of the Cochrane Haematological Malignancies Group.
    Trelle S; Higgins G; Kober T; Engert A
    J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
    [No Abstract]   [Full Text] [Related]  

  • 8. Third biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
    J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
    [No Abstract]   [Full Text] [Related]  

  • 9. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study.
    Zhao X; Gao F; Zhang X; Wang Y; Xu L; Liu K; Zhao X; Chang Y; Wei H; Chen H; Chen Y; Jiang Z; Huang X
    Sci China Life Sci; 2016 Nov; 59(11):1139-1148. PubMed ID: 27535422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields.
    Weaver CH; Tauer K; Zhen B; Schwartzberg LS; Hazelton B; Weaver Z; Lewkow L; Allen C; Longin K; Buckner CD
    J Hematother; 1998 Jun; 7(3):241-9. PubMed ID: 9621257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood stem cell transplantation.
    Bensinger W
    Cancer Treat Res; 1995; 76():169-93. PubMed ID: 7577334
    [No Abstract]   [Full Text] [Related]  

  • 15. A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.
    Moreau P; Kergueris MF; Milpied N; Le Tortorec S; Mahé B; Bulabois CE; Rapp MJ; Larousse C; Bataille R; Harousseau JL
    Br J Haematol; 1996 Dec; 95(3):527-30. PubMed ID: 8943896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hematopoietic recovery as a function of the number of autografted CD34+ cells: a retrospective study of 66 patients with malignant hematologic diseases].
    Boulassel MR; De Bruyère M; Nguyen BT; Straetmans N; Ferrant A
    Acta Clin Belg; 1999 Aug; 54(4):191-6. PubMed ID: 10544508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosimilar filgrastim (leucostim®) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®) and lenograstim (granocyte®): A retrospective multicenter study.
    Kayıkçı Ö; Tekgündüz E; Kaya AH; Göker H; Aslan A; İskender D; Namdaroglu S; Tetik A; Koçubaba Ş; Altuntaş F
    Transfus Apher Sci; 2017 Dec; 56(6):832-835. PubMed ID: 29162397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells.
    Kayal S; Sharma A; Iqbal S; Tejomurtula T; Cyriac SL; Raina V
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):140-7. PubMed ID: 24342104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
    Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
    Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation.
    Shimazaki C; Oku N; Uchiyama H; Yamagata N; Tatsumi T; Hirata T; Ashihara E; Okawa K; Goto H; Inaba T
    Bone Marrow Transplant; 1994 Mar; 13(3):271-5. PubMed ID: 7515300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.